| Literature DB >> 32659300 |
Maria Giulia Manzione1, Miquel Martorell2, Farukh Sharopov3, Namrata Ganesh Bhat4, Nanjangud Venkatesh Anil Kumar5, Patrick Valere Tsouh Fokou6, Raffaele Pezzani7.
Abstract
Plants are a natural source of bioactive compounds such as secondary metabolites. These molecules, also called phytochemicals, are fundamental for plant survival and often show therapeutic properties used for the treatment of human diseases. Asperuloside is a secondary metabolite which belongs to iridoid glycosides and is commonly present in the plant family Rubiaceae. In this review we aim to summarize the scientific knowledge on asperuloside, with a special emphasis on its pharmacological properties as anti-viral, anti-malarial, anti-protozoal, anti-tumorigenic, anti-hypertensive, anti-obesity, immunomodulatory, anti-inflammatory and antioxidant agent. Preclinical studies in animal models suggest that asperuloside has therapeutic potential that could be evaluated in humans. However, despite its tangible phytochemical characteristics, no clinical trial has been performed so far. Thus, we hope that this review will facilitate scientific dissemination of asperuloside pharmacological properties and encourage researchers to evaluate both pharmacokinetic and toxicity of asperuloside in animal models. This will be the first step towards clinical studies in humans.Entities:
Keywords: Asperuloside; Iridoid glycosides; Rubiaceae
Mesh:
Substances:
Year: 2020 PMID: 32659300 DOI: 10.1016/j.ejphar.2020.173344
Source DB: PubMed Journal: Eur J Pharmacol ISSN: 0014-2999 Impact factor: 4.432